簡易檢索 / 詳目顯示

研究生: 蔡勇男
論文名稱: 五爪金英甲醇萃取物中活性成分Tagitinin C的分離及抗癌活性
Identification and Anti-cancer Activity of Tagitinin C from Tithonia Diversifolia Methanolic Extract
指導教授: 張立雪
溫小娟
口試委員:
學位類別: 碩士
Master
系所名稱:
論文出版年: 2010
畢業學年度: 98
語文別: 中文
論文頁數: 87
中文關鍵詞: 五爪金英甲醇萃取物(TDM)Tagitinin C1H NMR細胞凋亡細胞自噬
外文關鍵詞: Tithonia diversifolia methanolic extract (TDM), Tagitinin C, 1H NMR, apoptosis, autophagy
相關次數: 點閱:1下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 五爪金英(Tithonia diversifolia (Hemsl.) A. Gray)是廣泛被民間使用的草藥,最常做為養肝、退火的苦茶成分之一,曾有文獻指出五爪金英對多種癌細胞株有抗癌的效果;五爪金英其主要活性成分為Tagitinin C。
    本研究將中草藥五爪金英甲醇萃取物(TDM)純化出來的Tagitinin C,經細胞實驗發現對於人類腦癌細胞U373及人類肝癌細胞Hep-G2具有毒殺效果。實驗結果顯示,針對U373及Hep-G2,加入TDM後24小時後結果發現其IC50分別為59.2 ± 3.7µg/mL和40.0 ± 2.0µg/mL。針對具有抗癌效果之TDM經過管柱分離,分離出各種不同極性的0~5% EtOAc/Hexane (TDM-EA-a), 10~20% EtOAc/Hexane (TDM-EA-b), 20~30% EtOAc/Hexane (TDM-EA-c), 30~60% EtOAc /Hexane (TDM-EA-d), 60~100% EtOAc/Hexane (TDM-EA-e), 1~100% MeOH/ EtOAc (TDM-EA-f),最後將TDM-EA-b、c、d利用半製備級HPLC進行分離與純化,純化後的物質重複以上細胞實驗,確認所純化的物質為抗癌有效成份,接著以核磁共振光譜(NMR)結構鑑定,結果發現有效成份為Tagitinin C其對於U373及Hep-G2的IC50分別約為6.1 ± 0.1µg/ mL和2.0±0.1µg/mL。
    在確定有效成分為Tagitinin C後,在U373發現caspase 3並沒有活化,另一方面經由流式細胞儀分析細胞凋亡也是沒有細胞凋亡的現象出現,然而在poly(ADP-ribose) polymerase-1 (PARP-1), ULK1, LC3-I, LC-II, p-p38則是有表現,其死亡的方式可能是走autophagy的模式;在Hep-G2發現caspase 3 和caspase 8皆有活化,流式細胞儀分析的結果:Tagitinin C處理後的Hep-G2其細胞週期中的次G14期(Sub-G1) 比例增加,故其殺死Hep-G2的方式可能是走細胞凋亡的模式。在以上的實驗可推斷Tagitinin C對於不同的癌細胞造成毒殺的方式會有所不同,未來有助於我們探討癌細胞被Tagitinin C殺死的機制。


    Tithonia diversifolia are used in bitter tea and traditional medicine in Taiwan. Pharmacological studies of Tithonia diversifolia showed that it has anti-diabetic, anti-malarial, anti-inflammatory, analgesic, and cancer chemopreventive activity. They are particularly rich in sesquiterpenoids and flavonoids and these sesquiterpenoids were evaluated for their potential as cancer chemopreventive agents in cell culture. Tagitinin C is the major sesquiterpenoid compound in Tithonia diversifolia. But their mechanisms of anti-cancer activity are still unknown. The Tithonia diversifolia methanolic extract (TDM), which showed anti-proliferative activity against human glioblastoma U373 and human hepatoma Hep-G2 cells with an IC50 value 59.2 ± 3.7µg/mL and 40.0 ± 2.0µg/mL, individually, was passed through silica gel chromatography and successively eluted with 0~5% EtOAc/Hexane (TDM-EA-A), 10~20% EtOAc/Hexane (TDM-EA-B), 20~30% EtOAc/Hexane (TDM-EA-C), 30~60% EtOAc/Hexane (TDM-EA-D), 60~100% EtOAc/Hexane (TDM-EA-E), 1~100% MeOH/ EtOAc (TDM-EA-F). Cytotoxicity- guided subfractions TDM-EA-B, TDM-EA-C, and TDM-EA-D which exhibited a comparatively higher anti-proliferative activity were isolated by semipreparative HPLC and then were proceeded structural identification and determination with 1H NMR. The isolated active compound was Tagitinin C, a kind of sesquiterpenoids. The IC50 was 6.1 ± 0.1µg/mL in U373 and 2.0±0.1µg/mL in Hep-G2 separatively treated with the isolated Tagitinin C from TDM. In flow cytometric analysis and caspase 3 expression, the results showed anti-proliferative effect was not induced by apoptosis in U373 after treatment of the isolated Tagitinin C. In, and poly(ADP-ribose) polymerase-1 (PARP-1), ULK1, LC3-I, LC-II, p-p38 expression, the anti-proliferation in U373 induced by Tagitinin C isolated from TDM was likely via autophagy. In caspase 3, caspase 8 protein expression and flow cytometric analysis , the results showed anti-proliferative effect in Hep-G2 was induced by apoptosis after treatment of the isolated Tagitinin C.
    In conclusion, the results showed anti-proliferative effect was not induced by apoptosis but induced by autophagy in U373, but the anti-proliferation in Hep-G2 was via apoptosis after treatment of the isolated Tagitinin C. Although many components in anti-cancer and their mechanism were further studied in the future, this is the first study to reveal that Tagitinin C isolated from TDM have anti-glioblastoma U373 and anti-hepatoma Hep-G2 potential .

    目 錄 頁次 中文摘要 I 英文摘要 III 致謝 V 目錄 VII 圖目錄 XII 表目錄 XIV 第一章 前言 1 1.1背景介紹 1 1.1.1五爪金英化學成分 2 1.1.2五爪金英相關研究 4 1.2抗癌機制 6 1.2.1細胞凋亡 6 1.2.2細胞自噬 8 1.3研究動機與目的 11 第二章 實驗儀器與實驗材料 12 2.1實驗試劑與藥品 12 2.1.1化學試劑與藥品 12 2.1.2生物試劑與藥品 12 2.1.3抗體 13 2.2實驗儀器 14 2.2.1分析用儀器 14 2.2.2生物試驗儀器 14 2.2.3共用常備儀器 15 2.3實驗材料 16 第三章 實驗方法與步驟 17 3.1實驗流程與架構 17 3.2萃取方法 17 3.2.1甲醇冷浸萃取(TDM) 17 3.3極性分離方法 17 3.3.1分層方法(partition) 17 3.3.2 Ethyl Acetate層分離純化 18 3.3.3 Thin layer chromatography (TLC) 薄層層析法 19 3.3.4半製備級HPLC分離條件 19 3.4細胞培養與實驗室藥品配製 20 3.4.1細胞來源 20 3.4.2細胞株解凍程序 20 3.4.3細胞株冷凍保存 21 3.4.4細胞培養方法 22 3.4.5細胞培養液配製 22 3.4.6胰蛋白酶(Trypsin-EDTA)之配製 23 3.4.7磷酸鹽緩衝液(phosphate buffered saline, PBS)之配製 23 3.5細胞數目計數 24 3.6細胞存活率試驗 (MTT assay) 25 3.7流式細胞儀(Flow cytometry) 25 3.8蛋白質分析 27 3.8.1細胞lysates收集 27 3.8.2蛋白質濃度測定 27 3.8.3十二烷基硫酸鈉-聚丙烯醯胺凝膠電泳 (Sodium dodecyl sulfate polyacrylamide gel electrophoresis,SDS-PAGE) 28 3.8.4西方轉漬法分析(Western blot analysis) 29 3.9統計分析 29 第四章 結果與討論 30 4.1萃取結果 30 4.1.1甲醇冷浸萃取(TDM) 30 4.2極性分離結果 30 4.2.1分層方法(partition) 30 4.2.2 Ethyl Acetate層分離純化 31 4.3半製備級HPLC分離結果 31 4.4五爪金英甲醇萃取物之細胞存活率 32 4.5五爪金英甲醇萃取物之六層不同極性區分層對細胞存活率的影響……………………………………………………...…………33 4.6高解析核磁共振光譜儀分析結果 33 4.7 Tagitinin C之細胞存活率 34 4.8 Tagitinin C對於正常老鼠肝細胞(Clone 9)之毒殺效果 35 4.9 Tagitinin C對於癌細胞細胞凋亡分析 35 4.10 Tagitinin C對癌細胞作用後細胞凋亡之分子機轉 36 4.11 Tagitinin C對癌細胞作用後細胞自噬之分子機轉 37 4.12 Tagitinin C對U373人類腦癌細胞之poly(ADP-ribose) polymerase表現量 38 第五章 結論 39 第六章 圖表及說明 41 第七章 參考文獻 68 附錄……………………………………………………………………. 75 附錄一……………………………………………………………. 75 附錄二……………………………………………………………. 76 附錄三……………………………………………………………. 77 附錄四……………………………………………………………. 78 附錄五……………………………………………………………. 79 附錄六……………………………………………………………. 80 附錄七……………………………………………………………. 81 附錄八……………………………………………………………. 82 附錄九……………………………………………………………. 83 附錄十……………………………………………………………. 84 附錄十一…………………………………………………………. 85 附錄十二…………………………………………………………. 86 附錄十三…………………………………………………………. 87 圖目錄 圖1五爪金英萃取純化流程圖……….……………………….……….41 圖2五爪金英甲醇萃取乙酸乙酯管柱區分重量圖………….….…….42 圖3以TLC方式點片動相為20~80%Ethyl Acetate/Hexane……….….44 圖4 TDM- EA-b以條件10% EA/ CH2Cl2,流速3ml/min經過半製備級HPLC之分析圖……………………………………………….45 圖5 TDM- EA-c以條件15% EA/ CH2Cl2,流速3ml/min經過半製備級HPLC之分析圖………………………………..……………….46 圖6 TDM- EA-d以條件20% EA/ CH2Cl2,流速3ml/min經過半製備級HPLC之分析圖……………………………..………………….47 圖7五爪金英純化物TDM-EA-d-9的H-NMR分析圖譜……….….48 圖8五爪金英粗萃物作用24小時後對U373之存活率的影響…….49 圖9 Hep-G2以五爪金英粗萃物加藥作用24小時其存活率之影響以五爪金英粗萃物作用24小時後Hep-G2對存活率的影響……….50 圖10 U373細胞以五爪金英分離出的分離物a~f加藥作用24小時之對存活率的影響……...…………………………………….……..51 圖11 U373細胞以Tagitinin C加藥作用24小時之對存活率的影響.52 圖12 Hep-G2細胞以Tagitinin C加藥作用24小時之對存活率的影.55 圖13 U373 和Clone 9細胞以Tagitinin C加藥作用24小時之對存活率的影響…………………...……………………..……………….54 圖14 Hep-G2 和Clone 9細胞以Tagitinin C加藥作用24小時之對存活率的影響…………………………………...……..…………….55 圖15 U373人類腦癌細胞經不同濃度Tagitinin C作用24小時之細胞型態觀察……………………………………….....……………….56 圖16 Hep-G2人類肝癌細胞經不同濃度Tagitinin C作用24小時之細胞型態觀察……………………………...………..……………….57 圖17 U373人類腦癌細胞分別經不同濃度Tagitinin C作用12小時後以流式細胞儀分析………………...……………..……………….58 圖18 U373人類腦癌細胞分別經不同濃度Tagitinin C作用24小時後以流式細胞儀分析………………...……………..……………….59 圖19 Hep-G2人類腦癌細胞分別經不同濃度Tagitinin C作用24小時後以流式細胞儀分析…………………...………..……………….60 圖20 Tagitinin C對U373細胞作用24小時對於caspase 3蛋白質表現之影響……………………………………...……..……………….61 圖21 Tagitinin C對Hep-G2細胞作用24小時對於caspase 8 和3蛋白質表現之影響……………………...……………..……………….62 圖22 Tagitinin C對U373細胞作用24小時對於p-p38蛋白質表現之影響……………………………………..……………...………….63 圖23 Tagitinin C對U373細胞作用24小時對於ULK1蛋白質表現之影響………………………………………..…………...………….64 圖24 Tagitinin C對U373細胞作用24小時對於LC3-Ⅰ蛋白質表現之影響………………………………..……………………...……….65 圖25 Tagitinin C對U373細胞作用24小時對於LC3-Ⅱ蛋白質表現之影響………………………………..……………………...……….66 圖26 Tagitinin C對U373細胞作用24小時對於PARP蛋白質表現之影響………………………………..……………………...……….67 表目錄 表1:五爪金英甲醇合併成a~f六組…………………………………45

    Bergamini E., Cavallini G., Donati A., Gori Z. The anti-ageing effects of caloric restriction may involve stimulation of macroautophagy and lysosomal degradation, and can be intensified pharmacologically.
    Biomed Pharmacother 2003; 57: 203-208.

    Bras M., Queenan B., Susin S A. Programmed cell death via mitochondria: different modes of dying. Biochemistry(Mosc) 2005;70(2):231-239.

    Chiang LC., Cheng HY., Chen CC., Lin CC. In vitro anti-leukemic and antiviral activities of traditionally used medicinal plants in Taiwan. The American Journal of Chinese Medicine 2004;32(5):695-704.

    Cos P., Hermans N., De BT., Apers S., Sindambiwe JB., Witvrouw M., De CE., Vanden BD., Pieters L., Vlietinck AJ. Antiviral activity of Rwandan medicinal plants against human immunodeficiency virus type-1 (HIV-1).Phytomedicine 2002; 9: 62-68.

    Degterev A., Boyce M., Yuan J .A decade of caspases. Oncogene 2003; 22: 8543-8567.

    do Céu de Madureira M, Martins AP, Gomes M, Paiva J,Proença da Cunha A, do Rosário V.Anti-malarial activity of medicinal plants used in traditional medicine in S. Tomé and Príncipe islands. J Ethnopharmacol 2002; 81: 23-29.

    Dorn BR., Dunn WA Jr., Progulske-Fox A. Bacterial interactions with the autophagic pathway.Cell Microbiol 2002; 4: 1-10.

    Dunn W A., Jr.Autophagy and related mechanisms of lysosome-mediated protein degradation. Trends Cell Biol 1994; 4: 139-143.

    Elufioye TO., Agbedahunsi JM. Antimalarial activities of Tithonia diversifolia (Asteraceae) and Crossopteryx febrifuga (Rubiaceae) on mice in vivo.Ethnopharmacol 2004; 93: 167-171(2004).

    Elufioye, TO., Agbedahunsi JM., Adesanya SA. 8-(2-methlybutanoyl) -3,10 epoxy-, 8-dihydroxyl-4, 11(13)-germacridien-12, 6-olide, a new sesquiterpene lactone from Tithonia diversifolia. Nigerian Journal of Natural Products and Medicine 2004;8: 74-76.

    Goffin E., da Cunha AP., Ziemons E., Tits M., Angenot L., Frederich M. Quantification of tagitinin C in Tithonia diversifolia by reversed-phase high-performance liquid chromatography.Phytochem Anal 2003; 14(6):378-80.

    Goffin E., Ziemons De Mol, P., De Madureira MD., Martins AP., Da Cunha AP.,Philippe G., Tits,M., Angenot, I., Fredrich, M., . In vitro antiplasmoidal activity of Tithonia diviersifolia and identification of its main active constituents: tagitinin C. Planta Medica 2002; 68:543-545.

    Gu JQ., Gills JJ., Park EJ., Mata-Greenwood E., Howthorne ME., Axelrod F., Chavez PI., Fong HHS., Kinghorn AD. Sesquiterpenoids from Tithonia diversifolia with potential cancer chemopreventive activity . Journal of natural products 2002; 65: 532-536.

    Hetts SW.To die or not to die: an overview of apoptosis and its role in disease. The Journal Of the American Medical Association 1998; 279:1699-1700.

    Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E,. Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. The EMBO Journal 2000;19(21):5720-5728.

    Kerr JF., Searle J. A suggested explanation for the paradoxically slow growth rate of basal-cell carcinomas that contain numerous mitotic figures. The Journal of Pathology 1972 ;107(1):41-44.

    Kirkegaard K., Taylor MP., Jackson WT. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nature Reviews Microbiology 2004;2: 301-314.

    Kuroda M., Yokosuka A., Kobayashi R., Jitsuno M., Kando H., Nosaka K., Ishii H., Yamori T., Mimaki Y.Sesquiterpenoids and flavonoids from the aerial parts of Tithonia diversifolia and their cytotoxic activity. Chemical & Pharmaceutical Bulletin 2007; 55(8): 1240-1244 .

    Kuwana T., Mackey MR., Perkins G., Ellisman MH, Latterich M., Schneiter R., Green DR., Newmeyer DD. Bid., Bax, and lipids cooperate to from superamolecular openings in the outer mitochondrial membrane. Cell 111: 331-342, 2002 .

    Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.

    Levine B., Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Developmental cell 2004;6 (4):463~477.

    Longo VD., Finch CE. Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 2003; 299:1342-1346.

    Majeski A E., Dice JF. Mechanisms of chaperone-mediated autophagy. The International Journal of Biochemistry & Cell Biology 2004;36 (12):2435-2444.

    Massey A., Kiffin R.,Cuervo AM. Pathophysiology of chaperone -mediated autophagy. The International Journal of Biochemistry & Cell Biology 2004 2420-2434.

    Meléndez A., Tallóczy Z., Seaman M., Eskelinen EL., Hall DH., Levine B. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003; 301:1387-1391.

    Miura T., Furuta K., Yasuda A., Iwamoto N., Kato M., Ishihara E., Ishida T., Tanigawa K. Antidiabetic effect of nitobegiku in KK-Ay diabetic mice. The American Journal of Chinese Medicine 2002; 30: 81-86.

    Miura T., Nosaka K., Ishii H., Ishida T. Antidiabetic effect of Nitobegiku, the herb Tithonia diversifolia, in KK-Ay diabetic mice. Biological & Pharmaceutical Bulletin 2005;28:2152-2154.

    Nabin C Baruah., Ram P Sharma.,K. P. Madhusudanan., Gopalakrishna Thyagarajan.,Werner Hem., Ramaswamy Murari. Sesquiterpene Lactones of Tithonia diversifolia. Stereochemistry of theTagitinins and Related Compounds'. The Journal of Organic Chemistry 1979; 44: 1831-1835.

    Owoyele VB., Wuraola CO., Soladoye AO., Olaleye SB. Studies on the anti-inflammatory and analgesic properties of Tithonia diversifolia leaf extract. The Journal of Ethnopharmacology 2004; 90: 317-321.

    Pereira PS., Dias DA., Vichnewski W., Nasi AM., Herz W. Sesquiterpene lactones from Brazilian Tithonia diversifolia.Phytochemistry 1997; 45: 1445-1448.

    Raghwendra Pal ., Kulshreshtha DK., Rastogi RP. Antileuckemic and other constituents of Tithonia tagitiflora desf 〔J〕. Journal of Pharmaceutical Science 1976a ;65 (6) : 918-920.

    Reggiori F., Klionsky DJ. Autophagy in the eukaryotic cell. Eukaryot Cell 2002; 1: 11-21.

    Rungeler P., Lyss G., Castro V., Mora G., Pahl H. L., Merfort I. Study of three sesquiterpene lactones from Tithonia diversifolia on their anti-inflammatory activity using the transcription factor NF-kappa B and enzymes of the arachidonic acid pathway as targets. Planta Medica 1998; 64: 588-593.

    Taiwo LB.,Makinde JO. Influence of water extract of Mexican sunflower (Tithonia diversifolia) on growth of cowpea (Vigna unguiculata). African Journal of Biotechnology 2005;4:355-360.

    Tona L., Kambu K., Mesia K., Cimanga K., Apers S., De Bruyne T., Pieters L., Totté J., Vlietinck AJ. Biological screening of traditional preparations from some medicinal plants used as antidiarrhoeal in Kinshasa, Congo.Phytomedicine 1999;6:59-66.

    Tona L., Kambu K., Ngimbi N., Mesia K., Penge O., Lusakibanza M., Cimanga K., De Bruyne T., Apers S., Totte J., Pieters L., Vlietinck AJ. Antiamoebic and spasmolytic activities of extracts from some antidiarrhoeal traditional preparations used in Kinshasa, Congo.Phytomedicine 2000;7(1):31-38.

    Vellai T., Takacs-Vellai K., Zhang Y., Kovacs AL., Orosz L., Müller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature2003; 426: 620.

    Ziemons E., Goffin E., Lejeune R., da Cunha AP., Angenot L., Thunus L. Supercritical carbon dioxide extraction of tagitinin C from Tithonia diversifolia. Journal of Supercritical Fluids 2005;33:53-59.

    陳德順 胡大維 台灣外來觀賞植物名錄 川流出版社印刷所發行,p.321,(1976)。

    詹宗憲,中草藥五爪金英在抗癌和抗氧化上的研究。元培科學技術學院,影像醫學研究所,碩士論文,095YUST7770004,(2007)。

    無法下載圖示 全文公開日期 本全文未授權公開 (校內網路)
    全文公開日期 本全文未授權公開 (校外網路)
    全文公開日期 本全文未授權公開 (國家圖書館:臺灣博碩士論文系統)
    QR CODE